Generic Drugs Current Affairs, GK & News

National Pharmacy Week celebrated in India

The Indian Pharmaceutical Association in collaboration with Delhi Pharmaceutical Trust celebrated the 59th National Pharmacy Week between November 16, 2020 and November 22, 2020. The National Pharmacy Week was celebrated under the theme Theme: Pharmacists: Frontline Health Professionals The Indian Pharmaceutical Association has been organizing the National Pharmacy Week every year during the third week ..

Month: 

Category: 

Topics: 

WHO launches plan for cheaper TB drugs

World Health Organization (WHO) has invited pharmaceutical companies around the world to submit proposals to manufacture affordable versions of newer medicines for treatment of drug resistant tuberculosis (DR-TB). It has now requested drug makers to submit Expression of Interest (EoI) for Bedaquiline and Delaminid, two new-generation drugs, recommended for DR-TB. The aim of this proposal ..

Month: 

Topics: 

WHO settles India, EU medicine dispute issue

The World Health Organisation (WHO) has dropped the term ‘counterfeit’ and retained ‘falsified’ to describe medicines of inferior quality. This decision was taken by a WHO’s technical working group on draft working definitions of substandard/spurious /falsely-labelled/falsified/counterfeit (SSFFC) medical products. It settles longstanding India, EU medicine dispute and battle about labelling of drugs. It is considered ..

Month: 

Topics: 

Delink drug prices from R&D costs: UN

The United Nations High-Level Panel on Access to Medicines has called for delinking drug prices from research and development (R&D) costs. The report submitted by panel calls for human rights to be placed over intellectual property laws of pharmaceutical companies and incoherence between them should be narrowed. Key Recommendations All countries must freely be able ..

Month: 

Topics: 

US FDA hikes fee for generic drug approvals

United state Food and Drugs Administration (USFDA) has hiked its fees by 30 percent for new generic drug applications. Earlier the fee for Abbreviated New Drug Applications (ANDAs) was 58,730 dollars and now has risen by 30 per cent to 76,030 US dollars. This fee is applicable from 1 October 2015. This move will hit Indian ..

Month: 

Topics: 

1 / 212